BIOYF Stock: BioSyent Inc. Stock Price, Analysis & Insights
Get live BIOYF stock price $9.99, comprehensive BioSyent Inc. stock analysis, charts, news, and expert forecast. Real-time BIOYF stock data and investment insights.
Loading chart data...
BioSyent Inc. (BIOYF) Overview
BioSyent Inc. (BIOYF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, BIOYF trades at $9.99 with a market capitalization of 114.27M . Over the past 52 weeks, BIOYF has traded between $7.63 and $12.00 , with the current price positioned at approximately 54% of this range . The st...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 114.27M
- Current price: $9.99
- 52-week range: $7.63 - $12.00
- P/E ratio: 17.84
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
BioSyent Inc., headquartered in Mississauga, Canada, is a specialized pharmaceutical firm that was established in 2006. The company, which changed its name from Hedley Technologies Inc. in June 2006 to underscore its focus on the pharmaceutical secto...
Company Information
- CEO
- René C. Goehrum
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 60
Contact Information
- Website
- https://www.biosyent.com
- Address
- 2476 Argentia Road
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 17.8)
✓ Lower volatility stock (Beta: 0.47) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for BioSyent Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for BioSyent Inc.
- ⚠Investors should consider how BioSyent Inc. fits within their overall portfolio allocation
Market Cap
114.27M
P/E Ratio (TTM)
17.84
Beta
0.47
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BIOYF with peer companies:
- Price
- $0.18
- Market cap
- 52.45M
- Price
- $0.00
- Market cap
- 2.06K
- Price
- $0.45
- Market cap
- 112.20M
- Price
- $0.08
- Market cap
- 34.43M
- Price
- $1.15
- Market cap
- 113.60M
- Price
- $6.25
- Market cap
- 96.62M
- Price
- $2.10
- Market cap
- 73.77M
- Price
- $0.14
- Market cap
- 44.76M
- Price
- $0.08
- Market cap
- 85.56M
- Price
- $5.10
- Market cap
- 214.67M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.